 Lisa Abuogi
Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 39 | 2023 | 2471 | 7.500 |
Why?
| | Anti-HIV Agents | 17 | 2023 | 669 | 5.400 |
Why?
| | Infectious Disease Transmission, Vertical | 18 | 2023 | 152 | 4.900 |
Why?
| | Kenya | 29 | 2023 | 98 | 3.760 |
Why?
| | Pregnancy Complications, Infectious | 9 | 2021 | 289 | 2.820 |
Why?
| | Anti-Retroviral Agents | 8 | 2023 | 207 | 2.110 |
Why?
| | Sexual Partners | 7 | 2023 | 164 | 1.850 |
Why?
| | Viral Load | 9 | 2023 | 406 | 1.790 |
Why?
| | Pregnant Women | 7 | 2023 | 132 | 1.550 |
Why?
| | Text Messaging | 4 | 2023 | 154 | 1.520 |
Why?
| | Intimate Partner Violence | 3 | 2021 | 69 | 1.340 |
Why?
| | Pregnancy | 23 | 2023 | 5555 | 1.300 |
Why?
| | Mothers | 7 | 2022 | 666 | 1.280 |
Why?
| | Breast Feeding | 5 | 2023 | 370 | 1.230 |
Why?
| | Infant | 24 | 2023 | 7992 | 1.210 |
Why?
| | Medication Adherence | 6 | 2022 | 538 | 1.200 |
Why?
| | Spouses | 4 | 2020 | 84 | 1.040 |
Why?
| | Social Support | 4 | 2023 | 538 | 1.010 |
Why?
| | Prenatal Care | 4 | 2020 | 257 | 1.010 |
Why?
| | HIV-1 | 2 | 2023 | 771 | 0.970 |
Why?
| | Fathers | 1 | 2023 | 45 | 0.880 |
Why?
| | Social Stigma | 6 | 2022 | 89 | 0.820 |
Why?
| | Female | 37 | 2023 | 60082 | 0.760 |
Why?
| | Fertilization | 1 | 2021 | 41 | 0.740 |
Why?
| | Zambia | 4 | 2023 | 69 | 0.730 |
Why?
| | Mentors | 3 | 2021 | 162 | 0.730 |
Why?
| | Interviews as Topic | 2 | 2020 | 596 | 0.640 |
Why?
| | Sustained Virologic Response | 1 | 2018 | 33 | 0.640 |
Why?
| | Continuity of Patient Care | 1 | 2020 | 255 | 0.620 |
Why?
| | Motivation | 1 | 2022 | 496 | 0.620 |
Why?
| | Humans | 45 | 2023 | 115879 | 0.610 |
Why?
| | Postpartum Period | 5 | 2023 | 281 | 0.600 |
Why?
| | Health Facilities | 2 | 2021 | 70 | 0.590 |
Why?
| | Health Facility Administration | 1 | 2017 | 6 | 0.580 |
Why?
| | Community Health Services | 2 | 2019 | 212 | 0.570 |
Why?
| | Truth Disclosure | 1 | 2017 | 39 | 0.570 |
Why?
| | Spouse Abuse | 1 | 2017 | 43 | 0.560 |
Why?
| | Young Adult | 13 | 2023 | 10510 | 0.560 |
Why?
| | Reminder Systems | 1 | 2018 | 162 | 0.530 |
Why?
| | Patient Dropouts | 1 | 2016 | 65 | 0.530 |
Why?
| | Child | 20 | 2023 | 18539 | 0.530 |
Why?
| | Health Resources | 1 | 2016 | 122 | 0.490 |
Why?
| | Male | 23 | 2023 | 56117 | 0.490 |
Why?
| | Adult | 19 | 2023 | 30822 | 0.490 |
Why?
| | Tuberculosis | 2 | 2014 | 244 | 0.460 |
Why?
| | Adolescent | 14 | 2023 | 17940 | 0.440 |
Why?
| | Point-of-Care Systems | 3 | 2023 | 150 | 0.430 |
Why?
| | Patient Compliance | 1 | 2016 | 524 | 0.410 |
Why?
| | Infant, Newborn | 7 | 2023 | 5084 | 0.390 |
Why?
| | Treatment Failure | 2 | 2023 | 332 | 0.360 |
Why?
| | Qualitative Research | 5 | 2023 | 967 | 0.350 |
Why?
| | Child, Preschool | 8 | 2022 | 9165 | 0.320 |
Why?
| | Developing Countries | 2 | 2021 | 242 | 0.290 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2023 | 1217 | 0.270 |
Why?
| | Case-Control Studies | 3 | 2018 | 3054 | 0.270 |
Why?
| | Prospective Studies | 4 | 2023 | 6279 | 0.260 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1405 | 0.260 |
Why?
| | Focus Groups | 3 | 2022 | 387 | 0.250 |
Why?
| | Retrospective Studies | 7 | 2023 | 12616 | 0.240 |
Why?
| | Colorado | 3 | 2023 | 4122 | 0.240 |
Why?
| | Infant Health | 1 | 2023 | 22 | 0.220 |
Why?
| | Maternal Health | 1 | 2023 | 44 | 0.220 |
Why?
| | Drug Resistance, Viral | 1 | 2023 | 99 | 0.220 |
Why?
| | Risk Factors | 4 | 2021 | 8715 | 0.220 |
Why?
| | Patient Acceptance of Health Care | 2 | 2019 | 682 | 0.210 |
Why?
| | Peripartum Period | 1 | 2022 | 9 | 0.210 |
Why?
| | Treatment Outcome | 5 | 2021 | 9164 | 0.200 |
Why?
| | Cross-Sectional Studies | 4 | 2020 | 4447 | 0.200 |
Why?
| | Telephone | 1 | 2023 | 153 | 0.200 |
Why?
| | Drug Resistance | 1 | 2022 | 162 | 0.200 |
Why?
| | Mass Screening | 2 | 2020 | 1024 | 0.200 |
Why?
| | Emigrants and Immigrants | 1 | 2023 | 111 | 0.200 |
Why?
| | Prevalence | 2 | 2020 | 2270 | 0.190 |
Why?
| | Organophosphates | 1 | 2022 | 90 | 0.190 |
Why?
| | Transition to Adult Care | 1 | 2022 | 60 | 0.190 |
Why?
| | Treatment Adherence and Compliance | 1 | 2021 | 18 | 0.190 |
Why?
| | Public Health Surveillance | 1 | 2021 | 61 | 0.190 |
Why?
| | Asymptomatic Infections | 1 | 2020 | 22 | 0.180 |
Why?
| | Health Personnel | 2 | 2023 | 579 | 0.180 |
Why?
| | Reward | 1 | 2022 | 208 | 0.180 |
Why?
| | Adenine | 1 | 2022 | 221 | 0.180 |
Why?
| | Patient Participation | 1 | 2023 | 362 | 0.180 |
Why?
| | Infant, Low Birth Weight | 1 | 2021 | 125 | 0.180 |
Why?
| | Symptom Assessment | 1 | 2021 | 121 | 0.170 |
Why?
| | Proportional Hazards Models | 3 | 2022 | 1088 | 0.170 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2021 | 221 | 0.170 |
Why?
| | Ambulatory Care | 1 | 2023 | 479 | 0.170 |
Why?
| | C-Reactive Protein | 1 | 2021 | 364 | 0.160 |
Why?
| | Hospitals | 1 | 2023 | 585 | 0.160 |
Why?
| | Disclosure | 1 | 2019 | 102 | 0.160 |
Why?
| | Emotions | 1 | 2023 | 480 | 0.160 |
Why?
| | Pregnancy Outcome | 1 | 2021 | 336 | 0.160 |
Why?
| | Odds Ratio | 1 | 2021 | 968 | 0.160 |
Why?
| | CD4 Lymphocyte Count | 1 | 2018 | 257 | 0.150 |
Why?
| | Diagnostic Tests, Routine | 1 | 2018 | 89 | 0.150 |
Why?
| | Research Design | 1 | 2023 | 949 | 0.150 |
Why?
| | Self Disclosure | 1 | 2017 | 59 | 0.150 |
Why?
| | HIV | 1 | 2018 | 209 | 0.150 |
Why?
| | Disease Management | 1 | 2021 | 563 | 0.140 |
Why?
| | Multicenter Studies as Topic | 1 | 2018 | 249 | 0.140 |
Why?
| | Rural Population | 2 | 2017 | 448 | 0.140 |
Why?
| | United States | 2 | 2023 | 12322 | 0.140 |
Why?
| | Comorbidity | 1 | 2021 | 1476 | 0.140 |
Why?
| | HIV Seropositivity | 1 | 2017 | 110 | 0.140 |
Why?
| | Marriage | 1 | 2017 | 106 | 0.130 |
Why?
| | Hospitalization | 2 | 2023 | 1766 | 0.130 |
Why?
| | Health Services Research | 1 | 2017 | 377 | 0.120 |
Why?
| | Isoniazid | 1 | 2014 | 52 | 0.110 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2590 | 0.110 |
Why?
| | Incidence | 2 | 2022 | 2336 | 0.110 |
Why?
| | Antitubercular Agents | 1 | 2014 | 170 | 0.100 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2020 | 1193 | 0.100 |
Why?
| | Surveys and Questionnaires | 2 | 2020 | 4675 | 0.100 |
Why?
| | Depression | 1 | 2020 | 1147 | 0.100 |
Why?
| | Mutation | 1 | 2022 | 3371 | 0.100 |
Why?
| | Delivery of Health Care | 1 | 2018 | 847 | 0.100 |
Why?
| | Nasopharynx | 2 | 2022 | 63 | 0.100 |
Why?
| | Prognosis | 1 | 2018 | 3344 | 0.090 |
Why?
| | Biomarkers | 1 | 2021 | 3474 | 0.090 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 991 | 0.090 |
Why?
| | Cohort Studies | 2 | 2022 | 4960 | 0.080 |
Why?
| | Logistic Models | 1 | 2013 | 1863 | 0.080 |
Why?
| | Time Factors | 1 | 2018 | 6182 | 0.070 |
Why?
| | North America | 1 | 2023 | 263 | 0.050 |
Why?
| | Point-of-Care Testing | 1 | 2022 | 29 | 0.050 |
Why?
| | Milk, Human | 1 | 2023 | 128 | 0.050 |
Why?
| | Africa, Northern | 1 | 2021 | 4 | 0.050 |
Why?
| | Adaptive Immunity | 1 | 2022 | 157 | 0.050 |
Why?
| | Trust | 1 | 2022 | 108 | 0.050 |
Why?
| | Oropharynx | 1 | 2020 | 36 | 0.050 |
Why?
| | Professional-Patient Relations | 1 | 2022 | 143 | 0.050 |
Why?
| | RNA, Viral | 1 | 2023 | 564 | 0.040 |
Why?
| | Income | 1 | 2021 | 170 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 178 | 0.040 |
Why?
| | Family Characteristics | 1 | 2020 | 154 | 0.040 |
Why?
| | Peer Group | 1 | 2019 | 207 | 0.040 |
Why?
| | House Calls | 1 | 2019 | 131 | 0.040 |
Why?
| | Poverty | 1 | 2021 | 444 | 0.040 |
Why?
| | Delivery, Obstetric | 1 | 2018 | 119 | 0.040 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 478 | 0.040 |
Why?
| | Gene Expression | 1 | 2022 | 1442 | 0.040 |
Why?
| | Pandemics | 1 | 2023 | 1339 | 0.030 |
Why?
| | Program Evaluation | 1 | 2017 | 841 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2020 | 2807 | 0.030 |
Why?
| | Aged | 1 | 2022 | 19296 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 27085 | 0.010 |
Why?
|
|
Abuogi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|